Adaptyv Biosystems Series A: Adaptyv raises $40M Series A to automate lab work for AI-designed proteins

DealMatrix gives you market-realistic EV/Sales and EV/EBITDA multiples for private companies, filtered by sector, stage and region, built on 20 years of data and IPEV-2025-compliant.